Manufacturers Life Insurance Company, The Tricida, Inc. Transaction History

Manufacturers Life Insurance Company, The

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 11, 2023	SELL	$8.51 - $13.6 $68,326 - $109,194	-8,029 Reduced 36.27%	14,105 $147,000
Q3 2022 Nov 03, 2022	SELL	$8.51 - $13.6 $68,326 - $109,194	-8,029 Reduced 36.27%	14,105 $148,000
Q2 2022 Aug 11, 2023	BUY	$7.31 - $11.85 $161,799 - $262,287	22,134 New	22,134 $214,000
Q2 2022 Aug 15, 2022	BUY	$7.31 - $11.85 $161,799 - $262,287	22,134 New	22,134 $217,000
Q1 2021 May 03, 2021	SELL	$4.52 - $7.8 $87,719 - $151,374	-19,407 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.37 - $9.46 $8,364 - $18,106	1,914 Added 10.94%	19,407 $137,000
Q2 2020 Aug 10, 2020	BUY	$21.21 - $31.55 $58,115 - $86,447	2,740 Added 18.57%	17,493 $447,000
Q1 2020 May 15, 2020	BUY	$18.43 - $38.04 $15,002 - $30,964	814 Added 5.84%	14,753 $325,000
Q4 2019 Feb 14, 2020	SELL	$29.6 - $43.71 $16,013 - $23,647	-541 Reduced 3.74%	13,939 $526,000
Q3 2019 Nov 12, 2019	BUY	$29.87 - $42.22 $17,025 - $24,065	570 Added 4.1%	14,480 $446,000
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $50,167 - $63,530	1,610 Added 13.09%	13,910 $549,000
Q1 2019 May 13, 2019	BUY	$19.96 - $38.62 $245,508 - $475,025	12,300 New	12,300 $475,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.